Literature DB >> 19457283

Patent foramen ovale and migraine: association, causation, and implications of clinical trials.

Stewart J Tepper1, Catalina Cleves, Frederick R Taylor.   

Abstract

Patent foramen ovale (PFO) appears to be associated with migraine with aura (MA), probably through cardiac shunting. PFOs may also be comorbid with cryptogenic strokes. Although multiple open-label, retrospective, and case-controlled studies have noted sometimes dramatic reductions of MA after PFO closure, the only prospective sham-controlled study of PFO closure for MA, MIST, was negative for all primary and secondary measures of migraine improvement. MIST did demonstrate an association between MA and severe PFO shunts prospectively. Difficulty with recruitment closed the MIST II and ESCAPE trials; the PREMIUM and PRIMA randomized controlled trials are ongoing at the time of this writing.

Entities:  

Mesh:

Year:  2009        PMID: 19457283     DOI: 10.1007/s11916-009-0037-6

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  46 in total

1.  The extent of right-to-left shunt fails to correlate with severity of clinical picture in migraine with aura.

Authors:  S Gori; N Morelli; S Fanucchi; S Gallerini; M L Manca; G Orlandi; L Murri
Journal:  Neurol Sci       Date:  2006-04       Impact factor: 3.307

2.  Shunt-associated migraine responds favorably to atrial septal repair: a case-control study.

Authors:  Gian P Anzola; Giovanni B Frisoni; Eva Morandi; Francesco Casilli; Eustaquio Onorato
Journal:  Stroke       Date:  2005-12-22       Impact factor: 7.914

3.  Prevalence of patent foramen ovale in patients with migraine.

Authors:  Asli Demirtaş Tatlidede; Buket Oflazoğlu; Seden Erten Celik; Ulker Anadol; Hulki Forta
Journal:  Agri       Date:  2007-10

4.  Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study.

Authors:  Irene Meissner; Bijoy K Khandheria; John A Heit; George W Petty; Sheldon G Sheps; Gary L Schwartz; Jack P Whisnant; David O Wiebers; Jody L Covalt; Tanya M Petterson; Teresa J H Christianson; Yoram Agmon
Journal:  J Am Coll Cardiol       Date:  2005-12-06       Impact factor: 24.094

5.  Patent foramen ovale in young stroke patients.

Authors:  M W Webster; A M Chancellor; H J Smith; D L Swift; D N Sharpe; N M Bass; G L Glasgow
Journal:  Lancet       Date:  1988-07-02       Impact factor: 79.321

6.  Association of interatrial shunts and migraine headaches: impact of transcatheter closure.

Authors:  Babak Azarbal; Jonathan Tobis; William Suh; Vicki Chan; Catherine Dao; Richard Gaster
Journal:  J Am Coll Cardiol       Date:  2005-02-15       Impact factor: 24.094

7.  Migraine headache relief after transcatheter closure of patent foramen ovale.

Authors:  Mark Reisman; Ryan D Christofferson; Jill Jesurum; John V Olsen; Merrill P Spencer; Kimberly A Krabill; Lance Diehl; Sheena Aurora; William A Gray
Journal:  J Am Coll Cardiol       Date:  2005-02-15       Impact factor: 24.094

8.  Migraines linked to intrapulmonary right-to-left shunt.

Authors:  John Thenganatt; Jacob Schneiderman; Robert H Hyland; John Edmeads; Jennifer L Mandzia; Marie E Faughnan
Journal:  Headache       Date:  2006-03       Impact factor: 5.887

9.  Migraine and subsequent risk of stroke in the Physicians' Health Study.

Authors:  J E Buring; P Hebert; J Romero; A Kittross; N Cook; J Manson; R Peto; C Hennekens
Journal:  Arch Neurol       Date:  1995-02

10.  Investigation between the S377G3 GATA-4 polymorphism and migraine.

Authors:  Chikhani Sherin; Fernandez Francesca; Poetter Karl; Toohey Brendan; Harvey Ron; Griffiths Lyn
Journal:  Open Neurol J       Date:  2008-07-25
View more
  5 in total

1.  Nonpharmacologic treatments for migraine and tension-type headache: how to choose and when to use.

Authors:  Robert A Nicholson; Dawn C Buse; Frank Andrasik; Richard B Lipton
Journal:  Curr Treat Options Neurol       Date:  2011-02       Impact factor: 3.598

2.  Migraine headaches following catheter ablation for atrial fibrillation.

Authors:  Amit Noheria; John Roshan; Suraj Kapa; Komandoor Srivathsan; Douglas L Packer; Samuel J Asirvatham
Journal:  J Interv Card Electrophysiol       Date:  2010-10-19       Impact factor: 1.900

Review 3.  Modern management of a patent foramen ovale.

Authors:  G S Kanaganayagam; I S Malik
Journal:  JRSM Cardiovasc Dis       Date:  2012-10-31

4.  Long-term follow-up after percutaneous closure of patent foramen ovale with Amplatzer PFO Occluder: a single center experience.

Authors:  Aleksander Araszkiewicz; Marek Grygier; Sylwia Iwańczyk; Olga Trojnarska; Maciej Lesiak; Stefan Grajek
Journal:  Postepy Kardiol Interwencyjnej       Date:  2016-02-11       Impact factor: 1.426

5.  Efficacy of patent foramen ovale closure for treating migraine: a prospective follow-up study.

Authors:  Yi Qi; Yushun Zhang; Xiaohui Luo; Gesheng Cheng; Yajuan Du; Rui Liu; Hui Xie; Yawen Cheng; Yichen Guo; Guogang Luo
Journal:  J Investig Med       Date:  2020-09-14       Impact factor: 2.895

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.